The role of aberrant crypt foci induced by the two heterocyclic amines 2-amino-3-methyl-irmidazo[4,5-f]quinoline (IQ) and 2-amino-1-methyl-6-phenyl-imidazo[4,5-b]pyridine (PhIP) in the development of colon cancer in mice

Cancer Letters

Volumn 110, Issue 1-2, 1996, Pages 187-192

  Kristiansen, Eva ^a  

^a National Food Agency of Denmark   (Denmark)

Author keywords

2 amino 1 methyl 6 phenyl imidazo 4,5 b pyridine (PhIP); 2 amino 3 methyl imidazo 4,5 f quinoline (IQ); Aberrant crypt foci; Heterocyclic amines; Mice

Indexed keywords

2 AMINO 1 METHYL 6 PHENYLIMIDAZO[4,5 B]PYRIDINE; 2 AMINO 3 METHYLIMIDAZO[4,5 F]QUINOLINE; CARCINOGEN; HETEROCYCLIC AMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COLON CARCINOGENESIS; CONTROLLED STUDY; FEMALE; INTESTINE CRYPT; MOUSE; NONHUMAN; PRECANCER; PRIORITY JOURNAL;

ANIMALS; CARCINOGENS; COLON; COLONIC NEOPLASMS; FEMALE; IMIDAZOLES; MICE; MICE, INBRED C57BL; NEOPLASMS, EXPERIMENTAL; PRECANCEROUS CONDITIONS; QUINOLINES;

ANIMALIA;

EID: 0030596190     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(96)04495-3     Document Type: Article

References (27)

1. [1] Eisenbrand, G. and Tang, W. (1993) Food-borne heterocyclic amines. Chemistry, formation, occurrence and biological activities, A literature review. Toxicology, 84, 1-82.
2. [2] Cho, K.R. and Vogelstein, B. (1992) Genetic alteration in the adenoma-carcinoma sequence, Cancer, 70, 1727-1731.
3. [3] Bird, R.P., McLellan, E.A. and Bruce, W.R. (1989) Aberrant crypts, putative precancerous lesions, in the study of the role of diet in the aetiology of colon cancer, Cancer Surv., 8, 189-200.
4. [4] Pretlow, T.P., Barrow, B.J., Ashton, W.S., O'Riordan, M.A., Pretlow, T.G., Jurcisek, J.A. and Stellato, T.A. (1991) Aberrant crypts: putative preneoplastic foci in human colonic mucosa, Cancer Res., 51, 1564-1567.
5. [5] Roncucci, L., Stamp, D., Medline, A., Cullen, J.B. and Bruce, W.R. (1991) Identification and quantification of aberrant crypt foci and microadenomas in the human colon, Hum. Pathol., 22, 287-294.
6. [6] Roncucci, L., Medline, A. and Bruce, W.R. (1991) Classification of aberrant crypt foci and microadenomas in human colon, Cancer Epidemiol. Biomarkers Prev., I, 57-60.
7. [7] Bird, R.P. (1995) Role of aberrant crypt foci in understanding the pathogenesis of colon cancer, Cancer Lett., 93, 55-71.
8. [8] Kristiansen, E., Meyer, O. and Thorup, I. (1996) The ability of two cooked food mutagens to induce aberrant crypt foci in mice. Eur. J. Cancer Prev., in press.
9. [9] Tudek, B., Bird, R.P. and Bruce, W.R. (1989) Foci of aberrant crypts in the colons of mice and rats exposed to carcinogens associated with foods, Cancer Res., 49, 1236-1240.
10. [10] Steffensen, I.L., Paulsen, J.E. and Alexander, J. (1996) The food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) increases intestinal tumor and aberrant crypt foci (ACF) formation in MIN/+ mice, Proc. Am. Assoc. Cancer Res., 37, 733.
11. [11] Ohgaki, H., Kusama, K., Matsukura, N., Morino, K., Hasegawa, H., Sato, S., Takayama, S. and Sugimura, T. (1984) Carcinogenicity in mice of a mutagenic compound 2-amino-3-methylimidazo[4,5-f]quinoline, from broiled sardine, cooked beef and beef extract, Carcinogenesis, 5, 921-924.
12. [12] Esumi, H., Ohgaki, H., Kohzen, E., Takayama, S. and Sugimura, T. (1989) Induction of lymphoma in CDF, mice by the food mutagen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, Jpn. J. Cancer Res., 80, 1176-1178.
13. [13] Sørensen, I.K., Mortensen, A., Kristiansen, E., van Kreijl, C., Adamson, R.H. and Thorgeirsson, S.S. (1996) Short-term carcinogenicity testing of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in ET-pim-1 transgenic mice, Carcinogenesis, 17, 101-107.
14. [14] Kristiansen, E., Mortensen, A. and Sørensen, I.K. (1996) Effects of long-term feeding with 2-amino-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in mice. Pharmacol. Toxicol., submitted.
15. [15] Kristiansen, E., Thorup, I. and Meyer, O. (1995) Influence of different diets on development of DMH-induced aberrant crypt foci and colon tumor incidence in Wistar rats, Nutr. Cancer, 23, 151-159.
16. [16] McLellan, E. and Bird, R.P. (1991) Effect of disulfiram on 1,2-dimethylhydrazine- and azoxymethane-induced aberrant crypt foci, Carcinogenesis, 12, 969-972.
17. [17] Sørensen, I.K., Kristiansen, E., Mortensen, A., van Kranen, H., van Kreijl, C., Fodde, R. and Thorgeirsson, S.S. (1996) Short-term carcinogenicity testing of a potent murine intestinal mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-o]pyridine (PhIP) in Apc1638N transgenic mice. Carcinogenesis, submitted.
18. [18] Bird, R.P. (1995) Further investigation of the effect of cholic acid on the induction, growth characteristics and stability of aberrant crypt foci in rat colon, Cancer Lett., 88, 201-209.
19. [19] Pretlow, T.P., O'Riordan, M.A., Somich, G.A., Amini, S.B. and Pretlow, T.G. (1992) Aberrant crypts correlate with tumor incidence in F344 rats treated with azoxymethane and phytate, Carcinogenesis, 13, 1509-1512.
20. [20] Zhang, X.-M., Stamp, D., Minkin, S., Medline, A., Corpet, D.E., Bruce, W.R. and Archer, M.C. (1992) Promotion of aberrant crypt foci and cancer in rat colon by thermolyzed protein, J. Natl. Cancer Inst, 84, 1026-1030.
21. [21] Magnuson, B.A., Carr, I. and Bird, R.P. (1993) Ability of aberrant crypt foci characteristics to predict colonic tumor incidence in rats fed cholic acid, Cancer Res., 53, 4499-4504.
22. 14C]IQ and MeIQx in the mouse, Toxicol. Lett., 44, 183-190.
23. [23] Bird, R.P. and Bruce, W.R. (1984) Damaging effect of dietary components to colon epithelial cells in vivo: effect of mutagenic heterocyclic amines, J. Natl. Cancer Inst., 73, 237-240.
24. [24] Dolara, P., Caderni, G., Bianchini, F. and Tanganelli, E. (1986) Nuclear damage of colon epithelial cells by the food carcinogen 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) is modulated by dietary lipids, Mutat. Res., 175, 255-258.
25. [25] McLellan, E.A. and Bird, R.P. (1988) Specificity study to evaluate induction of aberrant crypts in murine colons, Cancer Res., 48, 6183-6186.
26. [26] Carter, J.W., Lancaster, H.K., Hardman, W.E. and Cameron, I.L. (1994) Distribution of intestine-associated lymphoid tissue, aberrant crypt foci, and tumors in the large bowel of 1,2-dimethylhydrazine-treated mice, Cancer Res., 54, 4304-4307.
27. [27] Steele, V.E. and Kelloff, G.J. (1993) Evaluation of a rat colon crypt assay to identify chemopreventive agents compared to rodent colon tumor assay systems, Proc. Am. Assoc. Cancer Res., 34, 552.